- Issuer ticker
-
LAB
- Reported as of
-
01 Apr 2022
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
04 Apr 2022, 16:16:50 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Nicolas Barthelemy by Nicholas Khadder, Attorney-in-Fact
Key filing fact
Nicolas Barthelemy filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 04 Apr 2022.
Key facts
- This page summarizes Nicolas Barthelemy's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Apr 2022, 16:16.
Change
- Previous filing in this sequence was filed on 01 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $78,514
- Shares
- +20,993
- Change %
- +11%
- Price
-
$3.74
- Shares after
- 204,077
- Date
- 01 Apr 2022
- Ownership
- The Barthelemy 2001 Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $78,514
- Shares
- -20,993
- Change %
- -100%
- Price
-
$3.74
- Shares after
- 0
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,993
- Exercise price
- $3.74
* marks a reported price that did not pass the local price check.